雜志介紹

Immunology Letters雜志介紹

《Immunology Letters》是一本以Multi-Language為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)免疫學(xué)快報(bào)，本刊主要出版、報(bào)道醫(yī)學(xué)-IMMUNOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.3，最新CiteScore 指數(shù)為7.6。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• The imbalance of circulating monocyte subgroups with a higher proportion of the CD14+CD16+CD163+phenotype in patients with preeclampsia

  Author: Gong, Fengyan; Wang, Junwei; Lu, Nianhong; Wang, Jiangyuan; Wang, Jia; Shi, Xu; Cui, Miao; Cui, Lifeng

• The frequencies of lymphocyte subsets on ?day 30?correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation

  Author: Yao, Yanhua; Li, Bohan; Li, Jie; Yao, Di; Ling, Jing; Hu, Yixin; Fan, Liyan; Wan, Lin; Kong, Lingjun; Xiao, Peifang; Lu, Jun; Meng, Lijun; Li, Zhiheng; Hu, Shaoyan; Tian, Yuanyuan

• Construction of CAR-T cells targeting TM4SF1 and its anti-tumor capacity in ovarian cancer

  Author: Shen, Yijie; Liu, Guodi; Zhang, Qian; Tian, Xiaoli; Ouyang, Liming; Zhang, Lixin

• TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation

  Author: Zhou, Shouzhi; Yang, Zhao; Liu, Jiaxin; Ran, Maojuan

英文介紹

Immunology Letters雜志英文介紹

Immunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings.

Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.